Cargando…
Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis
PURPOSE: To compare the outcomes of radiation segmentectomy for early-stage hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) versus hepatitis C virus (HCV). MATERIALS AND METHODS: A retrospective analysis of consecutive patients with NAFLD- or HCV-related HCC...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295464/ https://www.ncbi.nlm.nih.gov/pubmed/37383543 http://dx.doi.org/10.2147/JHC.S414853 |
_version_ | 1785063427160408064 |
---|---|
author | De la Garza-Ramos, Cynthia Montazeri, S Ali Musto, Kaitlyn R Kapp, Melissa D Lewis, Andrew R Frey, Gregory Paz-Fumagalli, Ricardo Ilyas, Sumera Harnois, Denise M Majeed, Umair Patel, Tushar Toskich, Beau |
author_facet | De la Garza-Ramos, Cynthia Montazeri, S Ali Musto, Kaitlyn R Kapp, Melissa D Lewis, Andrew R Frey, Gregory Paz-Fumagalli, Ricardo Ilyas, Sumera Harnois, Denise M Majeed, Umair Patel, Tushar Toskich, Beau |
author_sort | De la Garza-Ramos, Cynthia |
collection | PubMed |
description | PURPOSE: To compare the outcomes of radiation segmentectomy for early-stage hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) versus hepatitis C virus (HCV). MATERIALS AND METHODS: A retrospective analysis of consecutive patients with NAFLD- or HCV-related HCC treated with radiation segmentectomy from 01/2017-06/2022 was performed. Eligibility criteria included solitary tumor ≤8 cm or up to 3 HCC ≤3 cm, ECOG 0–1, and absence of vascular invasion or extrahepatic spread. Imaging best response was assessed per modified Response Evaluation Criteria in Solid Tumors. Target tumor and overall progression, time-to-progression (TTP), and overall survival (OS) were calculated. All outcomes were censored for liver transplantation (LT). Complete pathologic response (CPN) was assessed in patients who underwent LT. RESULTS: Of 142 patients included (NAFLD: 61; HCV: 81), most had cirrhosis (NAFLD: 87%; HCV: 86%) and small tumors (median size NAFLD: 2.3 cm; HCV: 2.5 cm). Patients with NAFLD had higher BMI (p<0.001) and worse ALBI scores (p=0.003). Patients with HCV were younger (p<0.001) and had higher AFP levels (p=0.034). Median radiation dose (NAFLD: 508 Gy; HCV: 452 Gy) and specific activity (NAFLD: 700 Bq; HCV: 698 Bq) were similar between cohorts. Objective response was 100% and 97% in the NAFLD and HCV cohorts, respectively. Target tumor progression occurred in 1 (2%) NAFLD and 8 (10%) HCV patients. Target tumor TTP was not met for either cohort. Overall progression occurred in 23 (38%) NAFLD and 39 (48%) HCV patients. Overall TTP was 17.4 months (95% CI 13.5–22.2) in NAFLD and 13.5 months (95% CI 0.4–26.6) in HCV patients (p=0.86). LT was performed in 27 (44%) NAFLD and 33 (41%) HCV patients, with a CPN rate of 63% and 54%, respectively. OS was not met in the NAFLD cohort and was 53.9 months (95% CI 32.1–75.7) in the HCV cohort (p=0.15). CONCLUSION: Although NAFLD and HCV are associated with different mechanisms of liver injury, patients with early-stage HCC treated with radiation segmentectomy achieve comparable outcomes. |
format | Online Article Text |
id | pubmed-10295464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-102954642023-06-28 Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis De la Garza-Ramos, Cynthia Montazeri, S Ali Musto, Kaitlyn R Kapp, Melissa D Lewis, Andrew R Frey, Gregory Paz-Fumagalli, Ricardo Ilyas, Sumera Harnois, Denise M Majeed, Umair Patel, Tushar Toskich, Beau J Hepatocell Carcinoma Original Research PURPOSE: To compare the outcomes of radiation segmentectomy for early-stage hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) versus hepatitis C virus (HCV). MATERIALS AND METHODS: A retrospective analysis of consecutive patients with NAFLD- or HCV-related HCC treated with radiation segmentectomy from 01/2017-06/2022 was performed. Eligibility criteria included solitary tumor ≤8 cm or up to 3 HCC ≤3 cm, ECOG 0–1, and absence of vascular invasion or extrahepatic spread. Imaging best response was assessed per modified Response Evaluation Criteria in Solid Tumors. Target tumor and overall progression, time-to-progression (TTP), and overall survival (OS) were calculated. All outcomes were censored for liver transplantation (LT). Complete pathologic response (CPN) was assessed in patients who underwent LT. RESULTS: Of 142 patients included (NAFLD: 61; HCV: 81), most had cirrhosis (NAFLD: 87%; HCV: 86%) and small tumors (median size NAFLD: 2.3 cm; HCV: 2.5 cm). Patients with NAFLD had higher BMI (p<0.001) and worse ALBI scores (p=0.003). Patients with HCV were younger (p<0.001) and had higher AFP levels (p=0.034). Median radiation dose (NAFLD: 508 Gy; HCV: 452 Gy) and specific activity (NAFLD: 700 Bq; HCV: 698 Bq) were similar between cohorts. Objective response was 100% and 97% in the NAFLD and HCV cohorts, respectively. Target tumor progression occurred in 1 (2%) NAFLD and 8 (10%) HCV patients. Target tumor TTP was not met for either cohort. Overall progression occurred in 23 (38%) NAFLD and 39 (48%) HCV patients. Overall TTP was 17.4 months (95% CI 13.5–22.2) in NAFLD and 13.5 months (95% CI 0.4–26.6) in HCV patients (p=0.86). LT was performed in 27 (44%) NAFLD and 33 (41%) HCV patients, with a CPN rate of 63% and 54%, respectively. OS was not met in the NAFLD cohort and was 53.9 months (95% CI 32.1–75.7) in the HCV cohort (p=0.15). CONCLUSION: Although NAFLD and HCV are associated with different mechanisms of liver injury, patients with early-stage HCC treated with radiation segmentectomy achieve comparable outcomes. Dove 2023-06-23 /pmc/articles/PMC10295464/ /pubmed/37383543 http://dx.doi.org/10.2147/JHC.S414853 Text en © 2023 De la Garza-Ramos et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research De la Garza-Ramos, Cynthia Montazeri, S Ali Musto, Kaitlyn R Kapp, Melissa D Lewis, Andrew R Frey, Gregory Paz-Fumagalli, Ricardo Ilyas, Sumera Harnois, Denise M Majeed, Umair Patel, Tushar Toskich, Beau Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis |
title | Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis |
title_full | Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis |
title_fullStr | Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis |
title_full_unstemmed | Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis |
title_short | Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis |
title_sort | outcomes of radiation segmentectomy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease versus chronic viral hepatitis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295464/ https://www.ncbi.nlm.nih.gov/pubmed/37383543 http://dx.doi.org/10.2147/JHC.S414853 |
work_keys_str_mv | AT delagarzaramoscynthia outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT montazerisali outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT mustokaitlynr outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT kappmelissad outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT lewisandrewr outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT freygregory outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT pazfumagalliricardo outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT ilyassumera outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT harnoisdenisem outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT majeedumair outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT pateltushar outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis AT toskichbeau outcomesofradiationsegmentectomyforhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdiseaseversuschronicviralhepatitis |